Sourcing high-purity Nicotinamide Adenine Dinucleotide (NAD+) for institutional studies requires strict analytical verification, low endotoxin thresholds, and documented batch-to-batch consistency. PX1 Research serves as a premier USA-based NAD+ supplier, delivering verified research-grade coenzymes supported by lot-specific mass spectrometry and RP-HPLC documentation for in vitro and preclinical research applications.
Sourcing high-purity Nicotinamide Adenine Dinucleotide (NAD+) for institutional studies requires strict analytical verification, low endotoxin thresholds, and documented batch-to-batch consistency. PX1 Research serves as a premier USA-based NAD+ supplier, delivering verified research-grade coenzymes supported by lot-specific mass spectrometry and RP-HPLC documentation for in vitro and preclinical research applications.
A reliable NAD+ supplier provides laboratory-grade Nicotinamide Adenine Dinucleotide verified through Reverse-Phase High-Performance Liquid Chromatography (RP-HPLC) and Mass Spectrometry (MS) with guaranteed purity exceeding 98%. Qualified vendors supply lot-specific Certificates of Analysis (COAs), enforce strict endotoxin thresholds below 0.01 EU/mg, and manufacture compounds within GMP-compliant, USA-based facilities to ensure reproducible in vitro and preclinical experimental outcomes.
When procuring coenzymes and metabolic intermediates for biochemical research, investigators must evaluate the vendor's analytical transparency. Unverified chemical reagents frequently contain degradation products such as nicotinamide or adenosine monophosphate, which distort cellular assays and enzymatic kinetics. Securing research-grade NAD+ from an accredited USA facility ensures that chemical structure, molecular weight, and thermodynamic stability meet rigorous academic standards.
Nicotinamide Adenine Dinucleotide (NAD+) is an essential pyridine nucleotide coenzyme composed of two mononucleotides linked by a phosphate group: one containing an adenine base and the other a nicotinamide ring. Existing in both oxidized (NAD+) and reduced (NADH) forms, this dinucleotide acts as a central electron carrier in metabolic redox reactions. In cell-free and cell culture models, NAD+ functions as a critical electron acceptor during glycolysis, the tricarboxylic acid (TCA) cycle, and mitochondrial beta-oxidation.
Beyond its classical role in hydride transfer, NAD+ serves as a obligate substrate for NAD+-consuming enzymes, including sirtuins (SIRT1–SIRT7), poly(ADP-ribose) polymerases (PARPs), and cyclic ADP-ribose synthases (CD38/CD157). Enzymatic consumption of NAD+ cleaves the glycosidic bond between nicotinamide and ribose, releasing nicotinamide as a reaction product while transferring ADP-ribose to target proteins or generating secondary messengers. Detailed mechanistic overviews are accessible within our coenzyme research library.
In vitro and animal model studies indicate that intracellular NAD+ pools dictate the rate of mitochondrial oxidative phosphorylation and ATP synthesis. Preclinical literature demonstrates that declining NAD+ levels correlate with impaired complex I activity in the electron transport chain, increased production of reactive oxygen species (ROS), and compromised mitochondrial membrane potential. In rodent models of metabolic stress, restoring intracellular NAD+ availability sustains mitochondrial respiration and structural integrity.
Furthermore, preclinical investigation reveals that NAD+ availability modulates mitochondrial quality control through mitophagy and mitochondrial biogenesis. In vitro models exposed to NAD+ demonstrate increased activation of peroxisome proliferator-activated receptor gamma coactivator 1-alpha (PGC-1α) via SIRT1-mediated deacetylation. Researchers examining mitochondrial cross-talk frequently consult our specialized analyses on NAD+ bioenergetic pathways.
Sirtuins are class III histone deacetylases that require NAD+ as a co-substrate to remove acetyl groups from lysine residues on histones and non-histone proteins. Preclinical assays demonstrate that the Michaelis constant (Km) of SIRT1 for NAD+ closely mirrors physiological intracellular NAD+ concentration ranges, making enzymatic activity sensitive to fluctuations in coenzyme availability. In vitro cleavage assays show that elevated NAD+ levels accelerate SIRT1 activity, leading to chromatin condensation and gene silencing.
In addition to nuclear sirtuins, mitochondrial sirtuins SIRT3, SIRT4, and SIRT5 utilize NAD+ to regulate matrix enzymes involved in fatty acid oxidation, amino acid metabolism, and antioxidant defense. Research models investigating SIRT3 activation demonstrate enhanced deacetylation of manganese superoxide dismutase (MnSOD), which mitigates oxidative damage in isolated cell cultures.
In metabolic research, investigators often evaluate direct NAD+ supplementation alongside its biosynthetic precursors and peptide-based mitochondrial modulators. Direct NAD+ application in cell-free assays provides immediate substrate availability for PARP and sirtuin kinetics without requiring enzymatic conversion steps. Conversely, nucleoside precursors rely on endogenous salvage pathways involving nicotinamide phosphoribosyltransferase (NAMPT) and nicotinamide mononucleotide adenylyltransferases (NMNATs).
To contextualize bioenergetic intervention strategies, researchers frequently contrast direct coenzymes with targeted peptides. For instance, NMN research compounds function as immediate upstream precursors to NAD+, whereas mitochondrial-derived peptides like MOTS-c operate downstream by regulating nuclear gene expression under metabolic stress. Similarly, mitochondrial-targeting peptides like SS-31 bind directly to cardiolipin in the inner mitochondrial membrane to optimize electron transfer independently of pyridine nucleotide concentration.
Ensuring experimental reproducibility requires strict vendor compliance with analytical verification standards. Every lot of NAD+ supplied by PX1 Research undergoes rigorous testing using Reverse-Phase High-Performance Liquid Chromatography (RP-HPLC) coupled with Mass Spectrometry (MS). RP-HPLC quantifies chemical purity by separating the parent NAD+ molecule from potential synthesis or degradation impurities, confirming a purity baseline of ≥98%.
Mass Spectrometry establishes precise molecular weight identification, ensuring the exact monoisotopic mass matches the chemical formula C21H27N7O14P2. Furthermore, because bacterial endotoxins (lipopolysaccharides) alter cell culture signaling pathways and induce inflammatory responses in animal models, PX1 Research evaluates all batches via Chromogenic Reagent Assays to confirm endotoxin levels remain below strict institutional thresholds.
Lyophilized NAD+ exhibits high hygroscopic sensitivity and thermal instability. Upon receipt, solid samples should be stored at -20°C or -80°C in a desiccated environment protected from light. Prior to opening containers, vials must be allowed to equilibrate to room temperature to prevent condensation of ambient moisture, which accelerates hydrolysis of the pyrophosphate backbone.
For reconstitution in laboratory settings, NAD+ is readily soluble in sterile, deionized water or buffered aqueous solutions (such as PBS or Tris-HCl, pH 7.0–7.4) at concentrations up to 50 mg/mL. Because NAD+ degrades rapidly in aqueous solutions at room temperature or acidic/basic pH extremes, stock solutions should be prepared fresh, divided into single-use aliquots, and frozen immediately at -80°C. Freeze-thaw cycles must be strictly avoided to prevent non-enzymatic degradation into nicotinamide and ADP-ribose.
Institutional compliance standards demand complete traceability from raw material synthesis to final container distribution. Every container of NAD+ distributed by PX1 Research carries a unique lot number linked to a publicly accessible Certificate of Analysis. Independent, ISO 17025-accredited testing laboratories perform our analytical evaluations to provide unbiased verification of product identity, purity, and safety.
By maintaining strict ISO 17025 documentation and manufacturing within domestic, GMP-compliant facilities located in California and Arizona, PX1 Research eliminates supply chain vulnerabilities associated with overseas sourcing. Researchers can explore our complete directory of verified compounds across the PX1 Research catalog.
Academic institutions, biotechnology firms, and contract research organizations (CROs) require dependable supply chains capable of delivering high-volume compounds without batch variation. PX1 Research supports high-throughput screening projects and longitudinal preclinical trials by offering scaled supply arrangements through our institutional wholesale accounts.
Orders placed Monday through Friday ship same-day from our dual logistics facilities in California and Arizona, ensuring minimal transit times and preserving cold-chain integrity during domestic and international transit. Qualified laboratories receive customized analytical documentation, bulk packaging options, and dedicated account management for large-scale research initiatives.
What purity standards does PX1 Research guarantee for NAD+?
PX1 Research guarantees a chemical purity of ≥98% for all NAD+ lots, verified through Reverse-Phase High-Performance Liquid Chromatography (RP-HPLC) and Mass Spectrometry (MS). A lot-specific Certificate of Analysis (COA) is provided with every order.
How is NAD+ tested for bacterial endotoxin contamination?
Every production lot undergoes testing via a chromogenic Limulus Amebocyte Lysate (LAL) or equivalent kinetic assay to confirm endotoxin levels fall below strict laboratory safety thresholds (<0.01 EU/mg), ensuring compatibility with sensitive in vitro and animal models.
What is the recommended storage procedure for lyophilized NAD+?
Lyophilized NAD+ should be stored at -20°C or -80°C in a dry, dark environment. To prevent moisture condensation during handling, allow the vial to reach room temperature before opening.
How should NAD+ solutions be prepared and stored after reconstitution?
Reconstitute NAD+ using sterile, neutral-pH aqueous buffers (such as PBS, pH 7.2–7.4). Aliquot the solution into single-use volumes and freeze at -80°C. Avoid repeated freeze-thaw cycles and do not store reconstituted solution at room temperature.
What is the difference between direct NAD+ and precursors like NMN in cell culture studies?
Direct NAD+ provides immediate substrate availability for extracellular or cell-free enzymatic assays involving sirtuins and PARPs. Precursors such as NMN require cellular uptake and enzymatic conversion via intracellular salvage pathways before participating in NAD+-dependent processes.
Where are PX1 Research compounds manufactured and shipped from?
All PX1 Research compounds are manufactured in GMP-compliant facilities in the USA and tested by independent ISO 17025 accredited laboratories. Orders ship same-day (Monday through Friday) from distribution centers in California and Arizona.
Does PX1 Research support bulk or wholesale ordering for research facilities?
Yes, PX1 Research offers institutional supply agreements and bulk quantity tiers for universities, CROs, and industrial research laboratories through our wholesale procurement program.
All products are sold strictly for laboratory and research use only. Not for human or veterinary use, diagnosis, treatment or consumption. Statements have not been evaluated by the FDA.